Obstetrics & Gynecology in Dallas, GA
3 verified obstetrics & gynecology doctors in Dallas.
OB/GYNs provide women's reproductive health care, including pregnancy, childbirth, and gynecologic conditions.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Obosa Osawe, MD
Obstetrics & Gynecology
CMS Open Payments· $230.30 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$230.30
Total received
11
Transactions
7
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Obosa Osawe do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shannon Inci, MD
Obstetrics & Gynecology
CMS Open Payments· $181.82 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$181.82
Total received
9
Transactions
6
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Shannon Inci do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Garcia, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.